October 27, 2026

Sotera Health Company (SHC) Stock Analysis: A Solid 22.95% Potential Upside in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC) is capturing the attention of investors with its compelling 22.95% potential upside, according to recent analyst ratings. As a key player..

Schrodinger, Inc. (SDGR) Stock Analysis: Navigating Growth Amidst Challenging Metrics

Schrodinger, Inc. (NASDAQ: SDGR), a company at the intersection of healthcare and technology, is gaining attention for its pioneering work in computational platforms that drive drug..

Privia Health Group, Inc. (PRVA) Stock Analysis: Uncovering a 42% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA), a key player in the healthcare sector, is gaining attention for its robust growth prospects and compelling valuation metrics. As..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Revenue Growth and Analyst Optimism Signal a Promising 34% Upside

Kiniksa Pharmaceuticals International (NASDAQ: KNSA), a notable player in the biopharmaceutical sector, is making waves with its promising therapeutic developments. With a market capitalization of $5.61..

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis: Exploring an 82.63% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a biotechnology company based in Pasadena, California, is turning heads in the investment world with its cutting-edge RNA interference (RNAi) technology..

Immunocore Holdings plc (IMCR) Stock Analysis: A Biotech Powerhouse with 100% Upside Potential

Immunocore Holdings plc (NASDAQ: IMCR) stands out in the biotechnology sector with an impressive potential upside of 100.53%, according to analyst ratings. Headquartered in Abingdon, United..

QuidelOrtho Corporation (QDEL) Stock Analysis: Understanding the 6.51% Upside Potential

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector and the medical devices industry, presents a compelling case for investors seeking exposure to the..

Enovis Corporation (ENOV) Stock Analysis: A Promising 70% Upside in the Healthcare Sector

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with a potential upside of 70.53%...

PGIM Securitized Income ETF (PINC) Stock Analysis: Navigating Stability with a $4.08 Billion Market Cap

For individual investors seeking exposure to securitized credit investments, the PGIM Securitized Income ETF (PINC) stands out as a notable option. With a market capitalization of..

Mesoblast Limited (MESO) Stock Analysis: Exploring a Promising 198.63% Upside in the Biotechnology Sector

Mesoblast Limited (NASDAQ: MESO), a pioneering name in the biotechnology sector, has positioned itself as a formidable player in the realm of regenerative medicine. With a..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Understanding the Challenges and Opportunities in Biotech

Apogee Therapeutics, Inc. (NASDAQ: APGE), a prominent player in the biotechnology sector, presents a compelling case for investors interested in the healthcare space. Based in San..

Clover Health Investments (CLOV) Stock Analysis: Navigating a 17.87% Potential Upside in Healthcare Plans

Clover Health Investments, Corp (CLOV) is carving out a niche in the healthcare sector, primarily focusing on Medicare Advantage plans. With a market cap of $2.42..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Exploring a Potential 95% Upside Amidst Challenges

Brookdale Senior Living Inc. (BKD) stands at a pivotal moment for investors seeking opportunities in the healthcare sector, particularly within the medical care facilities industry. With..

Liquidia Corporation (LQDA): An Investor’s Guide to a Biopharma Powerhouse with 24% Upside Potential

Liquidia Corporation (NASDAQ: LQDA), a prominent player in the healthcare sector, is making waves in the biopharmaceutical landscape with its innovative approach to treating rare cardiopulmonary..

Twist Bioscience Corporation (TWST) Stock Analysis: Is the Biotech Innovator Poised for Growth?

Twist Bioscience Corporation (NASDAQ: TWST) is capturing investor attention in the biotechnology sector with its innovative approach to synthetic DNA manufacturing. As a key player headquartered..

Disc Medicine, Inc. (IRON) Stock Analysis: A 61.92% Upside Potential in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON) is capturing investor interest with a potential upside of 61.92%, driven by its innovative approach in the biotechnology sector. Headquartered in..

Ascentage Pharma Group Internat (AAPG): A Promising Biotech with 188% Potential Upside

Ascentage Pharma Group International (AAPG), a key player in the biotechnology sector, is capturing the attention of investors with its impressive growth potential and strategic focus..

Surgery Partners, Inc. (SGRY) Stock Analysis: Evaluating Market Performance Amid Healthcare Growth

Surgery Partners, Inc. (NASDAQ: SGRY), a prominent player in the healthcare sector, operates a network of surgical facilities across the United States. Known for its focus..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a Potential 141% Upside for Investors

MoonLake Immunotherapeutics (NASDAQ: MLTX), a promising player in the biotechnology sector, has captured the attention of investors with its ambitious approach to tackling inflammatory skin and..

AtriCure, Inc. (ATRC) Stock Analysis: A Strong Buy Consensus Despite High Valuation Metrics

AtriCure, Inc. (NASDAQ: ATRC) is making waves in the healthcare sector, presenting a compelling case for investors with its innovative medical instruments and an impressive market..

Search

Funds

October 27, 2026

Search

Funds

October 27, 2026

FTSE 100

Funds